crutches image

DrugsDisclosed.com has published new research looking into the impact of the pandemic on those with underlying health issues.

Dubbed a ‘medication Trustpilot’ platform, DrugsDisclosed.com analysed data from over 400 patient reviews from global users of the DrugStars medication app to explore the impact of the pandemic on those with underlying health issues.

Worryingly, the figures show that 54 percent said they feel the public is not supportive of those living with underlying health conditions, rising to 57 percent for the over 60s.

Advertisement | Continue story below

A fifth of those with underlying health conditions, who have had medical appointments cancelled as a result of the pandemic, now say they are more worried about their condition than normal, statistics reveal.

DrugsDisclosed.com says its findings will raise concerns around the treatment of those with underlying health conditions who are considered to be at a higher risk of developing severe symptoms from coronavirus.

Furthermore, whilst more at risk to serious COVID-19 symptoms, DrugsDisclosed.com research unveiled that patients are not unanimous in their support of lockdown. Nearly one third feel lockdown restrictions are worse than the fear of catching COVID-19. In addition, of those spoken to, 33 percent said they worry that they will be required to lockdown indefinitely.

With the Pfizer vaccine currently being rolled out to health and care workers, and to some people aged 80 and over who already have a hospital appointment, DrugsDisclosed.com found that some people are not comfortable with the idea of taking new medication.

Previous research from the medication platform found that 54 percent of patients would only take a coronavirus vaccine after it had been tested for at least a year.

DrugsDisclosed.com Founder and Former Professor in social pharmacy at the University of Copenhagen Claus Møldrup, said: “It is clear from our research that patients have not been listened to. For months people who are deemed to be the most vulnerable to Covid-19, have been told to stay at home whilst the rest of us try to get back to normal. Now we are expecting them to turn up in their droves to take a vaccine. No one has asked them if they are comfortable with that.

“More significantly, missed appointments and the growing worry around taking the wrong medication could lead to a breakdown of trust between patients and healthcare providers and impact the overall health of this vulnerable group.

“It is important that we bring patients on the journey and build trust. Not just us as citizens, but also governments and pharmaceutical companies who expect an uptake in a vaccine.”

DrugsDisclosed.com is a free service for patients, patient associations and authorities to access over three million medication experiences. DrugsDisclosed.com collates data from 352,044 patient reviews from global users of the DrugStars medication app. The service has over 55 million unique data points around medication reviews.

THIIS ROUND-UP
Join the 2,500+ mobility professionals who stay informed with THIIS' twice-weekly industry updates.
We respect your privacy
https://i2.wp.com/thiis.co.uk/wp-content/uploads/2019/01/crutches.jpg?fit=1000%2C702&ssl=1https://i2.wp.com/thiis.co.uk/wp-content/uploads/2019/01/crutches.jpg?resize=150%2C150&ssl=1Sarah SarsbyNewsroomReports & ResearchSector Newscoronavirus restrictions,COVID-19 research,DrugsDisclosed.com,pandemic research,Pfizer vaccine,UK lockdown,underlying health conditionsDrugsDisclosed.com has published new research looking into the impact of the pandemic on those with underlying health issues.Dubbed a ‘medication Trustpilot’ platform, DrugsDisclosed.com analysed data from over 400 patient reviews from global users of the DrugStars medication app to explore the impact of the pandemic on those with underlying...News, views & products for mobility, access and independent living professionals